Objective: AKT1 and GSK3B take part in one of the intracellular cascades activated by the D2 dopamine receptor (DRD2). This receptor is antagonized by antipsychotics and plays a role in the pathogenesis of antipsychotic-induced tardive dyskinesia (TD).
| INTRODUCTION
Iatrogenic tardive dyskinesia (TD) is a debilitating and potentially irreversible neurological side effect of chronic treatment with a number of different types of medication, primarily with antipsychotics (Cornett, Novitch, Kaye, Kata, & Kaye, 2017; Tenback & van Harten, 2011) . Typical antipsychotics are associated with higher, 30% incidence of TD, but incidence with atypical antipsychotics is still significant, incapacitating 20% of patients (Cornett et al., 2017; Stegmayer, Walther, & van Harten, 2018) . The involuntary movements affect the *These authors equally contributed to this work. orofacial area and trunk and limbs, defining orofacial and limb-truncal types of TD. There is no consensus on the pathogenic mechanisms behind these features, and different neurotransmitter systems may be involved, but one of the best known hypotheses postulates that the D2 dopamine receptor (DRD2; plays an important role (Stegmayer et al., 2018; Zai et al., 2018) .
Furthermore, the two recently FDA-approved drugs to treat TD, valbenazine and deutetrabenazine, decrease the availability of synaptic dopamine by inhibiting the vesicular monoamine transporter type 2 (Stahl, 2018; Zai et al., 2018) , which might also support the hypothesis that DRD2 is implicated in the pathogenesis. According to that hypothesis, blockade by antipsychotics of the inhibitory DRD2 of gamma-aminobutyric acid (GABAergic) medium spiny neurons (MSNs) in the striatum results in compensatory upregulation of a supersensitive type of these receptors, which in turn may lead to excessive inhibition of the GABAergic MSNs that take part in the indirect pathway of the extrapyramidal circuit (Stahl, 2018) . This inhibition would result in insufficient inhibition of the cortex with the net result of increased uncontrolled movements. Furthermore, the upregulated supersensitive DRD2 may enhance intracellular cascades that lead to suspected neurodegeneration of GABAergic MSNs of the indirect pathway, which would explain irreversible symptoms in some patients.
Apart from the well-known G protein-dependent DRD2 signaling involving inhibition of cAMP Greengard, 2001 ), another pathway is G protein-independent and involves AKT serine/threonine kinase 1 (AKT1) and glycogen synthase kinase 3β (GSK3B; Beaulieu, Del'guidice, Sotnikova, Lemasson, & Gainetdinov, 2011; Beaulieu, Gainetdinov, & Caron, 2009; Freyberg, Ferrando, & Javitch, 2010) . In the present study, we looked for evidence that supersensitive DRD2s are involved in the pathogenesis of TD, including suspected neurodegeneration of GABAergic MSNs of the indirect pathway, through activation of the G protein-independent DRD2 signaling. In particular, we evaluated association of functional single nucleotide polymorphisms (SNPs) in AKT1 and GSK3B with TD in schizophrenic patients, treated with typical and atypical antipsychotic drugs. The SNPs rs1130214 and rs3730358 in AKT1 were chosen because of association of the haplotype TC with lower protein levels of AKT1, which suggests impaired mRNA expression or processing (Emamian, Hall, Birnbaum, Karayiorgou, & Gogos, 2004) . The variant rs334558, found in the promoter of GSK3B, is also known to be functional, because it determines the expression level of GSK3B, possibly by regulating transcription factor binding to the promoter (Kwok et al., 2005) . Loonen & van Praag, 2007) . AIMS scores for Items 1 to 7 were transformed into a binary form (presence or absence of TD) with Schooler and Kane's criteria (Schooler & Kane, 1982) .
| Genetic analysis
A blood sample was obtained for DNA extraction and genotyping.
DNA was extracted from leukocytes in whole peripheral blood using the standard phenol-chloroform method. All genotyping was performed blind to the patient's clinical status.
A total of three SNPs in genes GSK3B (rs334558) and AKT1 (rs3730358 and rs1130214) were genotyped using the fluorogenic 5′-exonuclease TaqMan technology performed on the real-time polymerase chain reaction system "StepOnePlus" (Applied Biosystems, USA).
| Statistical analysis
Statistical analysis was carried out with SPSS software, release 17.
Pearson's chi-squared test was used for the between-group comparison of demographic and clinical parameters, as well as of genotypic and allelic frequencies at significance level α = 0.05. Association of genotypes and alleles with TD was also assessed with odds ratios and 95% confidence intervals. Deviation from Hardy-Weinberg equilibrium of genotypic frequencies was also calculated with a chisquared test. Additionally, one-way analyses of variance of sums of AIMS scores in groups with different genotypes were performed using an F -test and Levene's test.
| RESULTS
A total of 449 patients with schizophrenia, receiving antipsychotic treatment for more than 3 months, were recruited after obtaining informed consent. According to predefined criteria, 121 patients suffered from TD. Table 1 presents the main demographic and clinical parameters of the studied population. The patients with TD were significantly older, and the duration of schizophrenia in these patients was significantly longer than in patients without TD.
Additionally, patients with TD were taking higher doses of antipsychotics. In our sample, TD was diagnosed more often in men than in women.
There was no deviation from Hardy-Weinberg equilibrium. Of the three SNPs tested, neither was associated with TD, when genotypes and alleles were compared between the group of patients with TD and the group without it. Table 2 
| DISCUSSION
The G protein-independent DRD2 signaling does not involve cAMP . In particular, activation of this intracellular cascade results in downregulation of AKT1 that otherwise inhibits GSK3B.
As a result, increased activity of GSK3B is brought by activation of DRD2. These kinases play important roles in many aspects of the life of a cell, such as differentiation, proliferation, metabolism, and survival (Doble & Woodgett, 2003; Dummler & Hemmings, 2007; Emamian, 2012; Frame & Cohen, 2001) , including aspects relevant to psychiatric and neurological disorders and response to medication (Beaulieu et al., 2009; Emamian, 2012; Freyberg et al., 2010; Levchenko et al., 2018) . GSK3B is also known to activate apoptosis (Doble & Woodgett, 2003; Frame & Cohen, 2001) , which may explain suspected neurodegeneration of GABAergic MSNs of the indirect pathway, resulting in irreversible symptoms in some patients.
Although the studied SNPs are known to alter expression of the DRD2-coupled kinases AKT1 and GSK3B, our study did not find evidence that these variants are associated with antipsychotic-induced TD. In fact, previous studies of AKT1 and GSK3B showed implication of the two kinases in antipsychotic drug action (Beaulieu et al., 2009; Freyberg et al., 2010) , but not in the pathogenesis of TD. In particular, three previous studies that investigated association between two of these SNPs and TD also showed negative results, unless other variables were incorporated into the analyses (Park et al., 2009; Souza et al., 2010; Zai et al., 2008) . One of these studies reported association of TD with rs3730358 (AKT1) only when taking into account another SNP rs6275, found in DRD2 (Zai et al., 2008) . However, rs6275 was already found to be associated with TD (Zai et al., 2007) , so it is unclear to what degree rs3730358 contributes to the reported association. A second study (Park et al., 2009) also reported association with TD only when rs334558 (GSK3B) was analyzed together with the Val66Met polymorphism in the brainderived neurotrophic factor gene (BDNF; Miura et al., 2014) . The third study reported association of the SNP rs6438552, found in high linkage disequilibrium with rs334558 (GSK3B; Kwok et al., 2005) , only when age was incorporated as a covariate in the analysis . Age is the variable known to be robustly associated with TD (Cornett et al., 2017; Tenback & van Harten, 2011; Waln & Jankovic, 2013) , so it is unclear to what degree rs6438552 (as a proxy for rs334558) is important in the reported association. As suggested by these studies, AKT1 and GSK3B might play some role in the pathogenesis of antipsychotic-induced TD, possibly via interaction with 
